St. Jude Children’s Research Hospital shared a post on LinkedIn:
“St. Jude Children’s Research Hospital has received its third consecutive ‘exceptional’ rating from the National Cancer Institute for the seven-year renewal of its designation as a Comprehensive Cancer Center.
This is the highest rating the NCI awards, and St. Jude remains the first and only NCI-designated Comprehensive Cancer Center devoted solely to children.
NCI-designated Comprehensive Cancer Centers are leaders in translating scientific advances into clinical care, providing access to therapies and clinical trials not widely available elsewhere. These centers also play a crucial role in training future cancer researchers and clinicians, and in advancing public outreach and education.
The St. Jude Comprehensive Cancer Center brings together internationally recognized scientists and physicians who collaborate across five major research programs. Our vision is to ensure a future where every child with cancer can look forward to a long and healthy life, while sharing discoveries with the global scientific community to advance cures for children everywhere.
‘Our designation as a Comprehensive Cancer Center reflects our dedicated laboratory, clinical and survivorship research, as well as leadership in education and community outreach,’ said Charles Roberts, MD, PhD, St. Jude Executive Vice President and Comprehensive Cancer Center director. ‘Achieving exceptional status for the third consecutive time is a testament to the work of our faculty and staff members, and the impact this Center has on pediatric cancer research and treatment.’“
More posts featuring St Jude Children’s Research Hospital on OncoDaily.